col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Elsevier: Pathology
  original article Date Title Authors   All Authors
1 [GO] 2021―Sep―04 Multi-site point of care assessment of Abbott ID NOW rapid molecular test for SARS-CoV-2 in a low-prevalence setting Maryza Graham, Stephen Muhi, Tuyet Hoang, Susan A. Ballard, Julie McAuley, Jason C. Kwong, et al. (+2)
2 [GO] 2021―Aug―10 Use of emerging testing technologies and approaches for SARS-CoV-2: review of literature and global experience for the Australian context Maryza Graham, Susan A. Ballard, Shivani Pasricha, Belinda Lin, Tuyet Hoang, Timothy Stinear, et al. (+5)
3 [GO] 2021―Jul―20 Longitudinal evaluation of laboratory-based serological assays for SARS-CoV-2 antibody detection K.A. Bond, E. Williams, S. Nicholson, S. Lim, D. Johnson, B. Cox, et al. (+10)
4 [GO] 2021―Jun―24 Coronial cases: SARS-CoV-2 infection and Covid-19 Linda Iles
5 [GO] 2021―Jun―24 Coronial cases: SARS-CoV-2 infection and covid-19 Linda Iles
6 [GO] 2021―Jun―24 Coronial cases: SARS-CoV-2 infection and covid-19 Linda Iles
7 [GO] 2021―Jun―24 Clinical forensic medicine and Covid-19 challenges: the melbourne experience Janine Rowse, Nicola Cunningham, Jo Ann Parkin
8 [GO] 2021―Jun―24 Patient blood management - a review of accepted practice; with a focus on optimising patient outcomes during the current COVID-19 pandemic Bryony Ross, Lisa Clarke, Peter Freeman
9 [GO] 2021―Jun―24 COVID-19: 2020 VISION Mike Catton
10 [GO] 2021―Jun―24 Background, testing methods, and laboratory approaches to SARS coronavirus-2 (SARS-CoV-2) and covid19 William D. Rawlinson, Sebastiaan van Hal, Malinna Yeang, Anna Condylios, Zin Naing, Jane-Phan Au, et al. (+2)
11 [GO] 2021―Jun―24 Background, testing methods, and laboratory approaches to SARS coronavirus-2 (SARS-CoV-2) and Covid19 William D. Rawlinson, Sebastiaan van Hal, Malinna Yeang, Anna Condylios, Zin Naing, Jane-Phan Au, et al. (+2)
12 [GO] 2021―Jun―24 Background, testing methods, and laboratory approaches to sars coronavirus-2 (SARS-CoV-2) and covid19 William D. Rawlinson, Sebastiaan van Hal, Malinna Yeang, Anna Condylios, Zin Naing, Jane-Phan Au, et al. (+2)
13 [GO] 2021―Jun―24 Comparative evaluation and longevity of neutralising and binding antibodies for SARS-COV-2 Natalie Davidson, Jenny Evans, Jenny Robson
14 [GO] 2021―Jun―24 Expression of GPI-anchored SARS-CoV-2 receptor binding domain in mammalian cells for serological use M.L. Kernich, P.J. Adamson, J.J. Wang, L.P. Kris, B.L. Armour, D. Beroukas, et al. (+4)
15 [GO] 2021―May―18 SARS-CoV-2 antibodies in the Southern Region of New Zealand, 2020 Alyson Craigie, Reuben McGregor, Alana L. Whitcombe, Lauren Carlton, David Harte, Michelle Sutherland, et al. (+7)
16 [GO] 2021―Mar―20 SARS-CoV-2 viral load dynamics and real-time RT-PCR cycle threshold interpretation in symptomatic non-hospitalised individuals in New Zealand: a multicentre cross sectional observational study Andrew Fox-Lewis, Shivani Fox-Lewis, Jenna Beaumont, Dragana Drinković, Jay Harrower, Kevin Howe, et al. (+10)
17 [GO] 2020―Oct―08 Focus on SARS-CoV-2 and COVID-19 Sharon C-A Chen, William D. Rawlinson
18 [GO] 2020―Oct―08 Laboratory diagnosis of severe acute respiratory syndrome coronavirus 2 T. Gulholm, K. Basile, J. Kok, S.C.-A. Chen, W. Rawlinson
19 [GO] 2020―Oct―08 Virus isolation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for diagnostic and research purposes Gregory Walker, Anupriya Aggarwal, Sonia Underwood, Malinna Yeang, Zin Naing, Alberto Ospina Stella, et al. (+2)
20 [GO] 2020―Oct―05 The impact of viral transport media on PCR assay results for the detection of nucleic acid from SARS-CoV-2 P.D. Kirkland, M.J. Frost
21 [GO] 2020―Sep―30 Accuracy amidst ambiguity: false positive SARS-CoV-2 nucleic acid tests when COVID-19 prevalence is low K. Basile, S. Maddocks, J. Kok, D.E. Dwyer
22 [GO] 2020―Sep―30 Laboratory biosafety measures involving SARS-CoV-2 and the classification as a Risk Group 3 biological agent Alexa M. Kaufer, Torsten Theis, Katherine A. Lau, Joanna L. Gray, William D. Rawlinson
23 [GO] 2020―Sep―30 Comparative analysis of three laboratory based serological assays for SARS-CoV-2 in an Australian cohort N. Davidson, J. Evans, D. Giammichele, H. Powell, P. Hobson, B. Teis, et al. (+3)
24 [GO] 2020―Sep―30 Head-to-head evaluation on diagnostic accuracies of six SARS-CoV-2 serological assays Shaun S. Tan, Sharon Saw, Ka Lip Chew, Chan Yiong Huak, Candy Khoo, Anastacia Pajarillaga, et al. (+5)
25 [GO] 2020―Sep―29 Is prostate infarction and acute urinary retention a possible complication of severe COVID-19 infection? Sergio A.C. Duarte, Jessica G. Pereira, Alexandre Iscaife, Katia R.M. Leite, Alberto A. Antunes
26 [GO] 2020―Sep―22 Sample pooling is a viable strategy for SARS-CoV-2 detection in low-prevalence settings Brian S.W. Chong, Thomas Tran, Julian Druce, Susan A. Ballard, Julie A. Simpson, Mike Catton
27 [GO] 2020―Sep―22 Clinical evaluation of SARS-CoV-2 point-of-care tests Roselle s. Robosa, Indy Sandaradura, Dominic e. Dwyer, Matthew v.N. O’sullivan
28 [GO] 2020―Sep―21 Clinical evaluation of four commercial immunoassays for the detection of antibodies against established SARS-CoV-2 infection Kyra Y.L. Chua, Sara Vogrin, Intissar Bittar, Jennifer H. Horvath, Hari Wimaleswaran, Jason A. Trubiano, et al. (+2)
29 [GO] 2020―Sep―01 Implementation and evaluation of a novel real-time multiplex assay for SARS-CoV-2: in-field learnings from a clinical microbiology laboratory Eloise Williams, Katherine Bond, Brian Chong, Dawn Giltrap, Malcolm Eaton, Peter Kyriakou, et al. (+7)
30 [GO] 2020―Aug―19 SARS-CoV-2 in children: spectrum of disease, transmission and immunopathological underpinnings Phoebe C.M. Williams, Annaleise R. Howard-Jones, Peter Hsu, Pamela Palasanthiran, Paul E. Gray, Brendan J. McMullan, et al. (+2)
31 [GO] 2020―Aug―19 Contamination of SARS-CoV-2 RT-PCR probes at the oligonucleotide manufacturer Claire Y.T. Wang, Cameron Buckley, Cheryl Bletchly, Patrick Harris, David Whiley
32 [GO] 2020―Aug―12 Histopathology of cutaneous COVID-19 lesion: possible SARS-CoV-2 cytopathogenic effect Kinan Drak Alsibai, Celine Michaud, Alex Taquet, Magalie Demar, Romain Blaizot
33 [GO] 2020―Jul―10 Rapid deployment of pathology services to a remote Australian quarantine setting during the COVID-19 pandemic James Branley, Matthew O’Sullivan, Adam Polkinghorne, Marin Poljak, Dianne Stephens


[de][en]

Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.006 sec